Medical Journals

Immunogenicity and Protection Induced by Mycobacterium Tuberculosis Mce-2 and Mce-3 Mutants in a Balb/C Mouse Model of Progressive Pulmonary Tuberculosis.

Authors:
  • Aguilar L D
  • Infante E
  • Bianco M V
  • Cataldi A
  • Bigi F
  • Pando R Hernandez

From: Experimental Pathology Section, Department of Pathology, National Institute of Medical Sciences and Nutrition Salvador Zubiràn, Vasco de Quiroga 15, Tlalpan, Mexico City CP-14000, Mexico.

Vaccine

  • Publish Date: Mar 2006
  • ISSN: 0264-410X
  • Volume: 24
  • Issue: 13
  • Pages: 2333-42
  • Medium: Print
  • Language: English
  • Citation (JAMA): Aguilar L D, Infante E, Bianco M V, et al. Immunogenicity and Protection Induced by Mycobacterium Tuberculosis Mce-2 and Mce-3 Mutants in a Balb/C Mouse Model of Progressive Pulmonary Tuberculosis.. Vaccine Mar 2006;24:2333-42

Abstract

Mycobacterial proteins coded by the mammalian cell entry (mce) genes allow for cell invasion into the host. The Mycobacterium tuberculosismce-2 and mce-3 mutants have impaired synthesis of mce proteins and are attenuated in BALB/c mice. Intra-tracheal infection of Balb/c mice with either mce mutant induced lower but progressive production of IFN-gamma and TNF-alpha, as well as larger delayed type hypersensitivity (DTH) reactions, than their parental H37Rv strain. When used as a subcutaneous vaccine and, before challenge, both mutants were more attenuated than BCG in Balb/c and immunodeficient nude mice. Cell suspensions from lymph nodes and spleen from mce mutant vaccinated mice stimulated with mycobacterial culture filtrate antigens (CFA) or immunodominant antigens (ESAT-6, Ag85) produced more INF-gamma than BCG-vaccinated animals. Used as subcutaneous vaccines, 60 days before intra-tracheal challenge with the hypervirulent strain of M. tuberculosis (Beijing code 9501000), both mutants induced a higher level of protection than BCG; 72% and 63% of the mice vaccinated with the mce-2 and mce-3 mutants, respectively, survived for 16 weeks after the challenge as compared to 30% of those vaccinated with BCG. Likewise, there was less tissue damage (pneumonia) and lower colony forming units (CFU) in the mice vaccinated with either of the two mutants as compared to the findings in mice vaccinated with BCG. These data suggest that lack of mce-2 and -3 gene expression decreases virulence and increases immunogenicity of live vaccines, favouring their ability to protect against tuberculosis, which was better than the protection conferred by BCG.

Mesh Headings (Keywords): Animals, Antigens, Bacterial, BCG Vaccine, Bacterial Proteins, Male, Mice, Mice, Inbred BALB C, Mutation, Mycobacterium tuberculosis, Tuberculosis Vaccines, Tuberculosis, Pulmonary, Tumor Necrosis Factor-alpha, Vaccination, Vaccines, Attenuated, Virulence


Check for Full Text / PubMed Unique Identifier (PMID): 16388878


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.